In that 2024 study, patients with type 2 diabetes prescribed semaglutide had a 36-month NAION incidence of 8.9%, compared to 1.8% in patients taking non-GLP-1 diabetes medications
Tools like the GLP-1 plotter can help visualize your progress from the very first week
The redox cycling enzymes thioredoxin, thioredoxin reductase, sulfiredoxin, peroxiredoxin, GSH peroxidase, superoxide dismutase 1, and catalase, and several GSH S-transferases, which are the enzymes mediating the elimination of ROS, are all Nrf2 targets (242)
What are some common side effects of retatrutide
Women are more likely than men to report using GLP-1 drugs while there are not significant differences in use across race and ethnicity